APTAGEN Labs logo — We produce state-of-the-art target-recognition elements for...

APTAGEN Labs

We produce state-of-the-art target-recognition elements for diagnostics, therapeutics, and bio-industrial applications.

Founded 2004 United States United States 13 employees Biotechnology, Education +2

General Information

Company Name APTAGEN Labs
Founded Year 2004
Location United States United States
Founders / Decision Makers
Team member
Employees 13
Industries Biotechnology, Education, Health Care +1
Social

BounceWatch is an independent company data service, not affiliated with APTAGEN Labs. To contact APTAGEN Labs, visit aptagen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does APTAGEN Labs compare?

A PDF of APTAGEN Labs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting APTAGEN Labs soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About APTAGEN Labs

Aptagen, LLC is a biotechnology company founded in 2004, specializing in the production of state-of-the-art target-recognition elements for diagnostics, therapeutics, and bio-industrial applications. The company's slogan emphasizes their focus on cutting-edge solutions for various industries. Based in Jacobus, PA, Aptagen is strategically located near important institutions such as John Hopkins University and Hershey Medical Center. Their expertise lies in offering aptamer and aptabody custom-based services to replace antibodies in research, diagnostic platforms, drug discovery, and therapeutics. The company's operations commenced in 2006, showcasing their evolution in the biotechnology sector. Aptagen's positioning and specializations make it an intriguing prospect for investors seeking opportunities in the biotechnology and education domains. With a strong emphasis on innovation and tailored solutions, Aptagen, LLC presents a compelling case for potential venture capital interest.

Business keywords: aptamer, diagnostics, therapeutics, bio-industrial applications, antibody replacement, drug discovery, nano-technology

No funding data available for APTAGEN Labs yet.

APTAGEN Labs Alternatives & Competitors

View All Alternatives
APTAGEN Labs vs
Infinimmune
Infinimmune United States

Treating human disease with truly human therapeutics.

Seed
16 employees
Biotechnology, Health Care
APTAGEN Labs vs
SomaScan
SomaScan United States

Transforming research and healthcare with industry-leading proteomics

Post-IPO Equity
143 employees
Biotechnology, Health Care
APTAGEN Labs vs
Antiverse
Antiverse United Kingdom

Designing functional antibodies for the most challenging targets.

Series A
33 employees
AI, Biotechnology

FAQ About APTAGEN Labs

We produce state-of-the-art target-recognition elements for diagnostics, therapeutics, and bio-industrial applications.
APTAGEN Labs was founded in 2004.
APTAGEN Labs is headquartered in United States.
APTAGEN Labs operates in Biotechnology, Education, Health Care and Health and Wellness. Its work centres on aptamer, diagnostics, therapeutics and bio-industrial applications.
APTAGEN Labs has approximately 13 employees.
Top alternatives and competitors to APTAGEN Labs include Infinimmune, SomaScan, Antiverse, Oxford BioTherapeutics, LabGenius Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
APTAGEN Labs and Infinimmune are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for APTAGEN Labs, https://bouncewatch.com/company/aptagen-llc, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes